Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma

Sep 27, 2017Medical science monitor : international medical journal of experimental and clinical research

Higher Levels of Certain Immune Cells in Tumors Linked to Better Survival in Operable Esophageal Cancer

AI simplified

Abstract

Intraepithelial CD4+ lymphocytes were present in 44.2% of esophageal squamous cell carcinoma tissues, significantly higher than the 28.9% found in the stromal region.

  • Higher levels of intraepithelial CD4+ lymphocytes are significantly associated with longer overall survival in patients with esophageal squamous cell carcinoma.
  • Increased intraepithelial CD4+ lymphocyte infiltration was identified as an independent predictor for improved overall survival.
  • No prognostic value was observed for the infiltration of CD3+ or CD8+ lymphocytes in this study.
  • The infiltration of tumor-infiltrating lymphocytes showed an inverse association with the expression of programmed death-ligand 1 (PD-L1).

AI simplified

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • πŸ“š7 fresh studies
  • πŸ“plain-language summaries
  • βœ…direct links to original studies
  • πŸ…top journal indicators
  • πŸ“…weekly delivery
  • πŸ§˜β€β™‚οΈalways free